To include your compound in the COVID-19 Resource Center, submit it here.

J&J, MacroGenics in second antibody deal

MacroGenics Inc. (NASDAQ:MGNX) jumped $3.02 (17%) to $21.06 on Wednesday after granting the Janssen Biotech

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE